| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 153, Issue 10 4367-4377, Copyright © 1994 by American Association of Immunologists
ARTICLES |
A Cerwenka, D Bevec, O Majdic, W Knapp and W Holter
Institute of Immunology, VIRCC at SFI, University of Vienna, Austria.
TGF-beta 1 is known to modulate lymphocyte activation affecting cell proliferation and the production of cytokines and Igs. Little is known about the characteristics of T cells grown in the presence of TGF-beta 1. We have stimulated human T cells with PHA in the presence of TGF- beta 1 under serum-free conditions for 7 days and characterized the resulting cell population. TGF-beta 1 (0.0032 to 10 ng/ml) affected neither [3H]thymidine incorporation (day 4) nor cell yield (day 7) in these cultures. However, cells activated in the presence of TGF-beta 1 proliferated vigorously in secondary cultures and produced highly elevated amounts of IL-2 (12 +/- 3-fold enhancement of IL-2 production in response to CD2 plus CD28 stimulation compared with control cells, mean +/- SEM; n = 10). The enhancing effects of TGF-beta 1 were demonstrable over a wide range of concentrations (0.4 to 10 ng/ml). The increased IL-2 protein production was paralleled by a dramatic up- regulation of IL-2 mRNA. In addition, cells precultured with TGF-beta 1 responded with enhanced cluster formation in the secondary cultures. With regard to their phenotype, we observed an increased expression of the alpha E beta 7-integrin human mucosal lymphocyte-1 and of the CD2- restricted epitope CD2R, whereas the expression of CD11a was slightly decreased. In contrast, TGF-beta 1 did not influence the constitutive or activation-induced expression of CD4, CD8, CD45RA, CD45RO, CD25, CD71, CD54, CD58, CD59, and B7. We conclude that TGF-beta 1 supports the generation of human effector cells with a strongly enhanced capacity to respond to subsequent restimulation.
This article has been cited by other articles:
|
|
 |
|
  A. Thakkinstian, S. Dmitrienko, M. Gerbase-DeLima, D. O. McDaniel, P. Inigo, K. M. Chow, M. McEvoy, A. Ingsathit, P. Trevillian, W. H. Barber, et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data Nephrol. Dial. Transplant., September 1, 2008; 23(9): 3017 - 3023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Hauri-Hohl, S. Zuklys, M. P. Keller, L. T. Jeker, T. Barthlott, A. M. Moon, J. Roes, and G. A. Hollander TGF-{beta} signaling in thymic epithelial cells regulates thymic involution and postirradiation reconstitution Blood, August 1, 2008; 112(3): 626 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-L. Ling, N. Dulphy, P. Bahl, M. Salio, K. Maskell, J. Piris, B. F. Warren, B. D. George, N. J. Mortensen, and V. Cerundolo Modulation of CD103 Expression on Human Colon Carcinoma-Specific CTL J. Immunol., March 1, 2007; 178(5): 2908 - 2915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Zheng, L. Meng, J. H. Wang, M. Watanabe, M. L. Barr, D. V. Cramer, J. D. Gray, and D. A. Horwitz Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient Int. Immunol., February 1, 2006; 18(2): 279 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Leveen, M. Carlsen, A. Makowska, S. Oddsson, J. Larsson, M.-J. Goumans, C. M. Cilio, and S. Karlsson TGF-{beta} type II receptor-deficient thymocytes develop normally but demonstrate increased CD8+ proliferation in vivo Blood, December 15, 2005; 106(13): 4234 - 4240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-P. Kim, B.-G. Kim, J. Letterio, and W. J. Leonard Smad-dependent Cooperative Regulation of Interleukin 2 Receptor {alpha} Chain Gene Expression by T Cell Receptor and Transforming Growth Factor-{beta} J. Biol. Chem., October 7, 2005; 280(40): 34042 - 34047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Gunnlaugsdottir, S. M. Maggadottir, and B. R. Ludviksson Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-{beta}1 on CD4+ and CD8+ naive human T-cells Int. Immunol., January 1, 2005; 17(1): 35 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Eriksson, S. K. Meadows, C. R. Wira, and C. L. Sentman Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-{beta} J. Leukoc. Biol., September 1, 2004; 76(3): 667 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Zheng, J. H. Wang, M. N. Koss, F. Quismorio Jr., J. D. Gray, and D. A. Horwitz CD4+ and CD8+ Regulatory T Cells Generated Ex Vivo with IL-2 and TGF-{beta} Suppress a Stimulatory Graft-versus-Host Disease with a Lupus-Like Syndrome J. Immunol., February 1, 2004; 172(3): 1531 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Zheng, J. D. Gray, K. Ohtsuka, S. Yamagiwa, and D. A. Horwitz Generation Ex Vivo of TGF-{beta}-Producing Regulatory T Cells from CD4+CD25- Precursors J. Immunol., October 15, 2002; 169(8): 4183 - 4189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Leveen, J. Larsson, M. Ehinger, C. M. Cilio, M. Sundler, L. J. Sjostrand, R. Holmdahl, and S. Karlsson Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable Blood, June 28, 2002; 100(2): 560 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamagiwa, J. D. Gray, S. Hashimoto, and D. A. Horwitz A Role for TGF-{{beta}} in the Generation and Expansion of CD4+CD25+ Regulatory T Cells from Human Peripheral Blood J. Immunol., June 15, 2001; 166(12): 7282 - 7289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Santin, P. L. Hermonat, A. Ravaggi, S. Bellone, S. Pecorelli, J. J. Roman, G. P. Parham, and M. J. Cannon Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes J. Virol., May 15, 2000; 74(10): 4729 - 4737. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. E. Rojas, K. N. Balaji, A. Subramanian, and W. H. Boom Regulation of Human CD4+ alpha beta T-Cell-Receptor-Positive (TCR+) and gamma delta TCR+ T-Cell Responses to Mycobacterium tuberculosis by Interleukin-10 and Transforming Growth Factor beta Infect. Immun., December 1, 1999; 67(12): 6461 - 6472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chu, K. Hong, E. L. Berg, and R. O. Ehrhardt Tissue Specificity of E- and P-Selectin Ligands in Th1-Mediated Chronic Inflammation J. Immunol., November 1, 1999; 163(9): 5086 - 5093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fujihara, H. Fujita, K. Tsubota, K. Saito, K. Tsuzaka, T. Abe, and T. Takeuchi Preferential Localization of CD8+ {alpha}E{beta}7+ T Cells Around Acinar Epithelial Cells with Apoptosis in Patients with Sjogren's Syndrome J. Immunol., August 15, 1999; 163(4): 2226 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tsutsui and T. Kamiyama Transforming Growth Factor beta -Induced Failure of Resistance to Infection with Blood-Stage Plasmodium chabaudi in Mice Infect. Immun., May 1, 1999; 67(5): 2306 - 2311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Ohtsuka, J D Gray, M M Stimmler, and D A Horwitz The relationship between defects in lymphocyte production of transforming growth factor-{beta}1 in systemic lupus erythematosus and disease activity or severity Lupus, February 1, 1999; 8(2): 90 - 94. [Abstract] [PDF]
|
|
|
|
 |
|
 S. H. Han, S. S. Yea, Y. J. Jeon, K.-H. Yang, and N. E. Kaminski Transforming Growth Factor-Beta 1 (TGF-beta 1) Promotes IL-2 mRNA Expression Through the Up-regulation of NF-kappa B, AP-1 and NF-AT in EL4 Cells J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1105 - 1112. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. Chen, W. Jin, and S. M. Wahl Engagement of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA-4) Induces Transforming Growth Factor beta (TGF-beta ) Production by Murine CD4+ T Cells J. Exp. Med., November 16, 1998; 188(10): 1849 - 1857. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
